Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 2 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 1 day agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 9 hours agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 15 hours agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
The Gut-Skin Axis May Be the Key to Healthy, Glowing Skin
First for Women via Yahoo News· 6 days agoWhether we’re talking about brain fog, weight loss or the immune system, lately it seems it all...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 23 hours agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Jude Bellingham fans discuss hyperpigmentation over footballer's appearance
Yahoo Life UK· 15 hours agoRead more about skin conditions: How a healthy gut microbiome can give you better winter skin (Yahoo...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 8 hours agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Hongkongers told to safeguard against ‘flesh-eating’ bacteria when in Japan
South China Morning Post· 4 days agoAn infection of the “flesh-eating” bacteria Streptococcus pyogenes, or Group A streptococcus, can...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 23 hours agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...